{"organizations": [], "uuid": "a9d150aec805ac6e0a0adbb9ec7390e2dcfdb868", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-novo-says-semaglutide-reduces-bloo/brief-novo-says-semaglutide-reduces-blood-sugar-and-weight-more-than-dulaglutide-idUSFWN1PR0AH", "country": "US", "domain_rank": 408, "title": "BRIEF-Novo Says ‍Semaglutide Reduces Blood Sugar And Weight More Than Dulaglutide​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.643, "site_type": "news", "published": "2018-02-01T16:42:00.000+02:00", "replies_count": 0, "uuid": "a9d150aec805ac6e0a0adbb9ec7390e2dcfdb868"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novo-says-semaglutide-reduces-bloo/brief-novo-says-semaglutide-reduces-blood-sugar-and-weight-more-than-dulaglutide-idUSFWN1PR0AH", "ord_in_thread": 0, "title": "BRIEF-Novo Says ‍Semaglutide Reduces Blood Sugar And Weight More Than Dulaglutide​", "locations": [], "entities": {"persons": [], "locations": [{"name": "copenhagen", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "novo nordisk", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - NOVO NORDISK:\n* SAYS ‍SEMAGLUTIDE DEMONSTRATED SIGNIFICANT REDUCTIONS IN BLOOD SUGAR AND WEIGHT COMPARED WITH DULAGLUTIDE​\n* SAYS SUSTAIN 7 TRIAL SHOWED THAT PEOPLE WITH TYPE 2 DIABETES TREATED WITH ONCE-WEEKLY SEMAGLUTIDE EXPERIENCED STATISTICALLY GREATER REDUCTIONS IN HBA1C AND BODY WEIGHT COMPARED TO TREATMENT WITH DULAGLUTIDE​\n* SAYS SUSTAIN 7 TRIAL SHOWED ‍FROM A MEAN BASELINE OF 95.2 KG, BODY WEIGHT WAS REDUCED BY 4.6 KG IN PEOPLE TREATED WITH SEMAGLUTIDE 0.5 MG COMPARED WITH 2.3 KG IN PEOPLE TREATED WITH DULAGLUTIDE 0.75 MG​ Further company coverage: (Copenhagen newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T16:42:00.000+02:00", "crawled": "2018-02-02T12:46:40.009+02:00", "highlightTitle": ""}